Literature DB >> 18787933

Pharmacodynamic evaluation of oral estradiol nanoparticles in estrogen deficient (ovariectomized) high-fat diet induced hyperlipidemic rat model.

G Mittal1, G Chandraiah, P Ramarao, M N V Ravi Kumar.   

Abstract

PURPOSE: It is believed that estrogen deficiency contributes importantly to the pathogenesis of menopausal metabolic syndrome and symptoms can be ameliorated with estradiol therapy. The present study reports efficacy of 17-beta estradiol encapsulated nanoparticles in treating the postmenopausal dyslipidemic condition.
MATERIALS AND METHODS: Estradiol encapsulated poly(lactide-co-glycolide) (PLGA) nanoparticles were prepared by emulsion-diffusion-evaporation method and evaluated in estrogen deficient (ovariectomized) high fat diet induced hyperlipidemic rat model.
RESULTS: The results obtained showed that estradiol nanoparticles were equally/more effective in treatment of estrogen deficient hyperlipidemic conditions at three times reduced dose and frequency in comparison to that of drug suspension administered orally.
CONCLUSION: Together, these results demonstrate the ability of nanoparticles in improving oral bioavailability/efficacy of estradiol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787933     DOI: 10.1007/s11095-008-9725-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  37 in total

1.  Hypocholesterolemic action of the selective estrogen receptor modulator acolbifene in intact and ovariectomized rats with diet-induced hypercholesterolemia.

Authors:  Christian Lemieux; Yves Gélinas; Josée Lalonde; Fernand Labrie; Denis Richard; Yves Deshaies
Journal:  Metabolism       Date:  2006-05       Impact factor: 8.694

Review 2.  Cardiovascular effects of oestrogens.

Authors:  J C Stevenson
Journal:  J Steroid Biochem Mol Biol       Date:  2000-11-30       Impact factor: 4.292

Review 3.  The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual.

Authors:  A T Florence
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

Review 4.  Various actions of oestrogens on the vascular system.

Authors:  J C Stevenson
Journal:  Maturitas       Date:  1998-09-20       Impact factor: 4.342

5.  Chronic treatment with physiological doses of estradiol affects the GH-IGF-1 axis and fat metabolism in young and middle-aged ovariectomized rats.

Authors:  M Böttner; W Wuttke
Journal:  Biogerontology       Date:  2006-04       Impact factor: 4.277

6.  Nanoparticle uptake by the oral route: Fulfilling its potential?

Authors:  Alexander T Florence
Journal:  Drug Discov Today Technol       Date:  2005

7.  Biphasic effects of the natural estrogen 17beta-estradiol on hepatic cholesterol metabolism in intact female rats.

Authors:  P Parini; B Angelin; A Stavréus-Evers; B Freyschuss; H Eriksson; M Rudling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-07       Impact factor: 8.311

Review 8.  Sex steroids and insulin resistance.

Authors:  Callum Livingstone; Mary Collison
Journal:  Clin Sci (Lond)       Date:  2002-02       Impact factor: 6.124

Review 9.  Drug delivery systems for hormone therapy.

Authors:  Jin-Wook Yoo; Chi H Lee
Journal:  J Control Release       Date:  2006-03-13       Impact factor: 9.776

Review 10.  Benefits and risks of estrogen replacement therapy.

Authors:  R A Lobo
Journal:  Am J Obstet Gynecol       Date:  1995-09       Impact factor: 8.661

View more
  6 in total

Review 1.  Engineering poly(lactic-co-glycolic acid) (PLGA) micro- and nano-carriers for Controlled Delivery of 17β-Estradiol.

Authors:  Alesia V Prakapenka; Heather A Bimonte-Nelson; Rachael W Sirianni
Journal:  Ann Biomed Eng       Date:  2017-06-20       Impact factor: 3.934

2.  17-β Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylation.

Authors:  Dhaval Sharad Bendale; Pinakin Arun Karpe; Richa Chhabra; Sachin Prabhakarrao Shete; Heta Shah; Kulbhushan Tikoo
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

3.  Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy.

Authors:  R Ganugula; M Deng; M Arora; H-L Pan; M N V Ravi Kumar
Journal:  ACS Chem Neurosci       Date:  2019-01-17       Impact factor: 4.418

4.  Postmortem mitochondrial membrane permeability transition assessment of apoptotic cell death in brain and liver of insulin resistant, ovariectomised rats.

Authors:  Ebenezer I O Ajayi; Olorunfemi R Molehin; Alex E Iyoha; Divya S P Tallapragada; Omotade I Oloyede; Kulbhushan B Tikoo
Journal:  IBRO Neurosci Rep       Date:  2021-10-09

Review 5.  Biomaterials and advanced technologies for the evaluation and treatment of ovarian aging.

Authors:  Meng Wu; Yican Guo; Simin Wei; Liru Xue; Weicheng Tang; Dan Chen; Jiaqiang Xiong; Yibao Huang; Fangfang Fu; Chuqing Wu; Ying Chen; Su Zhou; Jinjin Zhang; Yan Li; Wenwen Wang; Jun Dai; Shixuan Wang
Journal:  J Nanobiotechnology       Date:  2022-08-11       Impact factor: 9.429

6.  Soybean-Hop Alleviates Estrogen Deficiency-Related Bone Loss and Metabolic Dysfunction in Ovariectomized Rats Fed a High-Fat Diet.

Authors:  Dasom Noh; Yeni Lim; Hansol Lee; Hyejin Kim; Oran Kwon
Journal:  Molecules       Date:  2018-05-17       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.